Professional Overview
Meisa Propst is a seasoned clinical operations executive with over 15 years of experience driving successful pharmaceutical and biotechnology programs. As the Vice President of Clinical Operations at InCarda Therapeutics, she is responsible for leading all aspects of the company's global clinical trial operations, including protocol development, study start-up, site management, and data oversight. Meisa is a strategic leader with a proven track record of optimizing clinical trial processes to enhance efficiency, reduce timelines, and deliver high-quality results.
Experience Summary
Current Role
As Vice President of Clinical Operations at InCarda Therapeutics, Meisa oversees the execution of the company's clinical development pipeline, with a focus on cardiovascular and rare disease therapies. She has been instrumental in streamlining clinical trial workflows, implementing rigorous quality control measures, and building high-performing cross-functional teams. Under Meisa's leadership, InCarda has successfully advanced multiple programs through late-stage clinical trials, positioning the company for regulatory submissions and commercialization.
Career Progression
Prior to joining InCarda, Meisa held roles of increasing responsibility in clinical operations at leading biopharmaceutical companies, including Sunesis Pharmaceuticals, BioMarin Pharmaceutical, Bavarian Nordic, and Cerus Corporation. In these positions, she was responsible for the planning, implementation, and oversight of complex global clinical trials, contributing to the advancement of novel therapies across diverse therapeutic areas. Meisa's strong operational expertise, coupled with her ability to navigate regulatory environments, has been crucial in driving the successful completion of numerous clinical programs.
Academic Background
Meisa holds a Bachelor of Science degree in Biology from the University of California, Davis, where she graduated with honors. Her academic background, combined with her extensive industry experience, has equipped her with a deep understanding of the scientific principles and regulatory requirements that underpin successful drug development.
Areas of Expertise
- Clinical trial design, planning, and execution
- Site selection, management, and monitoring
- Data management and quality assurance
- Cross-functional team leadership and collaboration
- Regulatory compliance and agency interactions
- Process optimization and continuous improvement
Professional Impact
Throughout her career, Meisa has played a pivotal role in advancing the development of innovative therapeutics. She has successfully led the execution of multiple global Phase II and Phase III clinical trials, contributing to the advancement of programs in cardiovascular, rare disease, and oncology indications. Meisa's ability to effectively manage complex projects, drive operational excellence, and foster strong partnerships with clinical sites and CROs has been instrumental in delivering high-quality data and accelerating the regulatory approval process for her clients.
Conclusion
Meisa Propst is a seasoned clinical operations executive with a proven track record of driving the successful development and commercialization of novel therapies. Her extensive industry experience, coupled with her strategic leadership and operational expertise, make her a valuable asset to the biopharmaceutical industry. Meisa is poised to continue making significant contributions to the advancement of innovative treatments that improve patient outcomes.
